BRIEF published on 06/17/2024 at 07:05, 9 months 20 days ago Innate Pharma reveals promising results for SAR443579/IPH6101 in blood cancers Sanofi Innate Pharma SAR443579 Leukemia Blood Cancer
BRIEF published on 06/17/2024 at 07:05, 9 months 20 days ago Innate Pharma dévoile des résultats prometteurs pour le SAR443579/IPH6101 dans des cancers du sang Sanofi Innate Pharma SAR443579 Leucémie Cancer Du Sang
PRESS RELEASE published on 06/17/2024 at 07:00, 9 months 20 days ago Inside Information / Other news releases Innate Pharma shares updated results from the Sanofi developed blood cancer Phase 1/2 SAR443579/IPH6101 trial, showing promising clinical efficacy and safety in patients with R/R AML Sanofi Innate Pharma Blood Cancer NK Cell Engager Phase 1/2 Trial
PRESS RELEASE published on 06/17/2024 at 07:00, 9 months 20 days ago Informations privilégiées / Autres communiqués Innate Pharma présente de nouveaux résultats sur l'essai de phase 1/2 mené par Sanofi évaluant le NK Cell Engager SAR443579/IPH6101 dans divers cancers du sang lors du congrès annuel de l'EHA 2024 Étude De Phase 1/2 Innate Pharma NK Cell Engager SAR443579/IPH6101 Cancers Du Sang
BRIEF published on 05/28/2024 at 07:05, 10 months 10 days ago Innate Pharma announces its participation in upcoming investor conferences Biotechnology Investor Conferences Immunotherapy Health Innate Pharma
BRIEF published on 05/28/2024 at 07:05, 10 months 10 days ago Innate Pharma annonce sa participation à de prochaines conférences investisseurs Immunothérapie Santé Conférences Investisseurs Innate Pharma Biotechnologies
PRESS RELEASE published on 05/28/2024 at 07:00, 10 months 10 days ago Informations privilégiées / Autres communiqués Innate Pharma annonce sa participation à des conférences investisseurs mondiales à venir. Détails des conférences et objectif de la société biotechnologique axée sur les immunothérapies contre le cancer Biotechnologie Immunothérapie Cancer Conférences Investisseurs Innate Pharma
BRIEF published on 05/23/2024 at 22:05, 10 months 14 days ago Results of the Combined General Meeting of Innate Pharma Voting Results Supervisory Board General Assembly Innate Pharma
BRIEF published on 05/23/2024 at 22:05, 10 months 14 days ago Résultats de l'Assemblée Générale Mixte d'Innate Pharma Assemblée Générale Conseil De Surveillance Innate Pharma Résultats De Vote
PRESS RELEASE published on 05/23/2024 at 22:00, 10 months 14 days ago Inside Information / Other news releases Innate Pharma announces the voting results of its 2024 AGM. Quorum at 44.92%. Re-election of two Supervisory Board members. Details available on company's website Voting Results Supervisory Board Quorum 2024 AGM Innate Pharma
Published on 04/07/2025 at 18:00, 2 hours 14 minutes ago BrooQLy Inc. (BRQL) dba Dynamic Aerospace Systems Acquires Assets of Vayu (US) Inc., Impossible Aerospace Corporation, and Global Autonomous Corporation from Alpine 4 Holdings (ALPP) for $14,990,000
Published on 04/07/2025 at 14:30, 5 hours 44 minutes ago Newsmax Enters into Standby Equity Purchase Agreement of Up to $1.2 Billion With Yorkville Advisors
Published on 04/07/2025 at 14:30, 5 hours 44 minutes ago Sparta Provides Update on Delay in Filing Annual Financial Statements
Published on 04/07/2025 at 14:00, 6 hours 14 minutes ago NOA Lithium Advances Towards 2025 Water Exploration at Rio Grande Project
Published on 04/07/2025 at 19:00, 1 hour 14 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 31 MARS 2025 au 04 AVRIL 2025
Published on 04/07/2025 at 19:00, 1 hour 14 minutes ago u-blox Divests Dual Mode Cellular-Satellite Communications Business to Trident IoT
Published on 04/07/2025 at 18:53, 1 hour 20 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/07/2025 at 18:06, 2 hours 7 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 04/07/2025 at 18:00, 2 hours 14 minutes ago EUROPLASMA: EXERCICE DU QUATRIÈME INVESTOR CALL
Published on 04/07/2025 at 19:00, 1 hour 14 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/07/2025 at 19:00, 1 hour 14 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES MARS 2025
Published on 04/07/2025 at 19:00, 1 hour 14 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/07/2025 at 19:00, 1 hour 14 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES MARS 2025
Published on 04/07/2025 at 18:00, 2 hours 14 minutes ago SMTPC - Communiqué sur la mise à disposition du Rapport annuel 2024
